These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2288384)
1. Improvement of action myoclonus by an administration of 5-hydroxytryptophan and carbidopa in a child with muscular subsarcolemmal hyperactivity. Nakano K; Hayakawa T; Shishikura K; Ohsawa M; Suzuki H; Fukuyama Y Brain Dev; 1990; 12(5):516-20. PubMed ID: 2288384 [TBL] [Abstract][Full Text] [Related]
2. Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor. Magnussen I; Dupont E; Engbaek F; de Fine Olivarius B Acta Neurol Scand; 1978 Apr; 57(4):289-94. PubMed ID: 307327 [TBL] [Abstract][Full Text] [Related]
3. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. Van Woert MH; Rosenbaum D; Howieson J; Bowers MB N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457 [TBL] [Abstract][Full Text] [Related]
4. L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent. Growdon JH; Young RR; Shahani BT Neurology; 1976 Dec; 26(12):1135-40. PubMed ID: 1086988 [TBL] [Abstract][Full Text] [Related]
5. Palatal myoclonus treated with 5-hydroxytryptophan and a decarboxylase-inhibitor. Magnussen I; Dupont E; Prange-Hansen A; de Fine Olivarius B Acta Neurol Scand; 1977 Mar; 55(3):251-53. PubMed ID: 300537 [No Abstract] [Full Text] [Related]
6. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa. Thal L; Sharpless N; Wolfson L; Engel J; Katzman R Trans Am Neurol Assoc; 1976; 101():48-52. PubMed ID: 1088459 [No Abstract] [Full Text] [Related]
17. Pathological findings in a case of hypoxic myoclonus treated with 5-hydroxytryptophan and a decarboxylase inhibitor. De Léan J; Richardson JC; Rewcastle NB Adv Neurol; 1986; 43():215-23. PubMed ID: 2418647 [TBL] [Abstract][Full Text] [Related]